Search

everythinglearnresearchcommunity

for

Search:↓

Adding chemotherapy to tamoxifen improves survival for older breast cancer patients with positive nodes.

SARMs may be an effective treatment for a certain type of breast cancer by blocking cancer growth and spread.

Scalp cooling is largely ineffective in preventing hair loss from breast cancer chemotherapy.

The hair keratin gene KRT81 is found in both normal and breast cancer cells and helps them invade surrounding tissues.

Honey and bee pollen can help reduce menopausal symptoms in breast cancer patients.

Dihydrotestosterone causes p27 protein breakdown in ovarian and breast cancer cells by binding with SKP2.

Chemotherapy can cause significant hair thinning and changes in hair texture, while tamoxifen has a smaller effect.

Topical minoxidil improves hair loss in 80% of women with breast cancer undergoing endocrine therapy.

Hair and scalp pain is more common and severe in breast cancer patients on chemotherapy than those on tamoxifen.

CDK4/6 inhibitors have improved treatment outcomes for certain advanced breast cancer patients.

A young woman with severe symptoms of CPAN improved with intensive treatment but needed a leg amputation.

PRP treatment may help improve hair density and thickness in breast cancer patients with therapy-induced hair loss.

Scalp cooling therapy helps preserve hair during chemotherapy for most patients.

Nutraceuticals that promote hair growth do not reduce tamoxifen's effectiveness in breast cancer treatment.

A specific hair protein variant increases the spread of breast cancer and is linked to worse survival rates.

The CNC® prosthetic system improved body image in breast cancer patients with hair loss from chemotherapy but did not significantly change their psychological wellbeing.

Nutritional education reduces chemotherapy side effects and improves health in breast cancer patients.

Hair growth supplements do not reduce the effectiveness of the breast cancer treatment tamoxifen.

Women with PCOS may have a reduced ability to fight breast tumor cells over time.

The trial will test if YH0618 granule prevents hair loss in breast cancer patients during chemotherapy.

Using a niacinamide cream can improve life quality for breast cancer patients during chemotherapy.

Formestane is a preferred second-line treatment for advanced breast cancer in postmenopausal women because it's effective and has fewer side effects.

Taking 5α-reductase inhibitors does not significantly increase the risk of breast cancer in men.

The combination of gemcitabine and vinorelbine is effective and safe for treating elderly patients with advanced breast cancer previously treated with anthracyclines and taxanes.

The document explains how to create detailed biological pathways using genomic data and tools, with examples of hair and breast development.

Eribulin-based chemotherapy is more effective and has fewer side effects for advanced triple-negative breast cancer.

Different types of fibroblasts play specific roles in wound healing and cancer, which could help improve treatments.

Certain nutraceuticals may enhance hair growth without affecting the cancer-fighting properties of tamoxifen.

Hair growth-promoting nutraceuticals do not block the cancer-fighting effects of tamoxifen and may enhance its action.